Cirrhotic or fibrotic liver tissue causes reduced serum Se concentrations, and a recent report indicated a gradual decrease of serum SELENOP concentrations in non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) [19]. Here, SELENOP is linked to metabolic dysfunction-associated steatotic liver disease.